PROPOFOL is a widely used anesthetic drug and does not prolong corrected QT interval as much as other anesthetic agents, including midazolam. 1Propofol is also used for induction and maintenance of general anesthesia, even in patients with either congenital or acquired long QT syndrome. 2However, we experienced marked prolongation of the QT interval during anesthesia with propofol to allow mechanical ventilation in a patient with acute myocardial infarction.

A 71-yr-old woman was admitted to our hospital because of acute anterior myocardial infarction. On admission, her pulse rate was 129 beats/min, and her blood pressure was 204/120 mmHg. An electrocardiogram showed QS pattern and ST elevation in V1–V3 and normal QRS duration (80 ms). QT interval corrected by heart rate (QTc) according to Bazett's formula 3was 440 ms (fig. 1A). Serum potassium was 3.2 mEq/l, calcium was 8.9 mg/dl, and magnesium was 2.0 mg/dl. Blood gas analysis revealed pH 6.96, Pao275.9 mmHg, Paco2106.2 mmHg, base excess −11.3, and HCO323.4 mEq/l. The patient was intubated for ventilatory support. Propofol was given intravenously for induction (100 mg or 1.7 mg/kg) and maintenance (1.7 mg · kg−1· h−1) of sedation to allow mechanical ventilation. Four hours later, the QT interval was markedly prolonged as compared with the baseline value, and the QTc interval was prolonged to 690 ms (fig. 1B). QRS duration was not affected. At that time, serum concentrations of electrolytes still remained within the physiologic range; potassium was 3.9 mEq/l, calcium was 8.9 mg/dl, and magnesium was 2.0 mg/dl. Drugs concomitantly used were heparin (8,000 U/day), nitroglycerin (0.15 mg/h), dopamine (2.0 μg · kg−1· min−1), and piperacillin (4 g/day). Fortunately, lethal ventricular tachyarrhythmias, such as torsade de pointes, were not induced. The QTc interval was shortened to 490 ms after withdrawal of propofol (fig. 1C). Serum potassium was 3.9 mEq/l and calcium was 9.8 mg/dl, but magnesium was not measured at this point. Administration of propofol was repeated for challenge, and the QTc interval was prolonged again (fig. 1D). The QRS duration was 100 ms, and serum concentrations of electrolytes remained unchanged (potassium was 3.9 mEq/l and calcium was 10.0 mg/dl). Instead of propofol, midazolam (0.15 mg · kg−1· h−1) was given without prolongation of the QT interval. The patient has been free from any arrhythmic events for 1 yr after discharge. QT prolongation has not been documented at each visit of our outpatient clinic.

Fig. 1. Effects of propofol on QT interval. Electrocardiogram on admission (A ) and after the administration of propofol (B ). QTc interval was prolonged from 440 to 690 ms. QTc prolongation disappeared after withdrawal (C ) and was reproduced with readministration (D ) of propofol. Although R-R interval was also shortened after withdrawal of propofol (C ), QTc was shortened disproportionately with shortening of R-R interval. All electrocardiograms were recorded at a standard gain (1 mV/10 mm) and paper speed (25 mm/s). On admission, echocardiography showed the presence of pericardial effusion (550 ml). The R-wave amplitude increased in accordance with reduction of the pericardial effusion.

Fig. 1. Effects of propofol on QT interval. Electrocardiogram on admission (A ) and after the administration of propofol (B ). QTc interval was prolonged from 440 to 690 ms. QTc prolongation disappeared after withdrawal (C ) and was reproduced with readministration (D ) of propofol. Although R-R interval was also shortened after withdrawal of propofol (C ), QTc was shortened disproportionately with shortening of R-R interval. All electrocardiograms were recorded at a standard gain (1 mV/10 mm) and paper speed (25 mm/s). On admission, echocardiography showed the presence of pericardial effusion (550 ml). The R-wave amplitude increased in accordance with reduction of the pericardial effusion.

Close modal

Many causes are known to induce prolongation of QT interval: antiarrhythmic drugs, psychotropic drugs, changes in electrolyte concentrations, lesions of the central nervous system, and changes in sympathetic tone. 4Several investigators described unexpected, life-threatening ventricular tachyarrhythmias, sudden cardiac arrest, and death during general anesthesia in patients suffering from undiagnosed long QT syndrome. 5The effect of anesthetic agents on QT interval has been studied. McConachie et al . 3reported that propofol prolonged the QT interval significantly, but the prolongation was small as compared with thiopentone. During induction of anesthesia with propofol, the QTc interval remained below the upper limit (440 ms) of the normal range in patients with normal QT intervals. In contrast, methohexital and midazolam did prolong the QT interval to exceed the upper limit. 2Other investigators reported both propofol and midazolam did not change the QTc interval significantly. 6Furthermore, sevoflurane prolonged the QTc interval significantly, and that was fully reversible when propofol was substituted for sevoflurane. 7,8 

The mechanism of QT prolongation during anesthesia might be due to a reduction in sympathoadrenergic activity with a concomitant increase in vagal tone. Sympathetic nerve activity was inhibited and sensitivity of baroreflex was decreased during anesthesia with propofol. 9 

Propofol inhibits L-type calcium channel directly and shortens the duration of action potential in isolated cardiac myocytes. 10This effect is significantly greater than that on K+currents. 11Both thiopentone and midazolam also have similar effects on inward Ca2+current. 11The mean open time of single sodium channels was significantly reduced with propofol. 12Taken together, the effects of propofol on the QT interval are quite complicated.

In the present case, the mechanism for QT prolongation remains unclear. There were no apparent causes for QT prolongation except the administration of propofol. QT prolongation disappeared after withdrawal of propofol and was reproduced with challenge test with propofol. In patients with coronary artery disease, prolongation of the QT interval could be associated with polymorphic ventricular tachycardia, known as torsade de pointes, and sudden death. 13This was, however, not supported by other investigators. 14,15Although ventricular tachyarrhythmias were not induced in our patient, propofol should be given cautiously in patients with acute myocardial infarction.

The authors thank Akira Masuda, M.D. (Associate Professor, Department of Anesthesiology, Toyama Medical and Pharmaceutical University, Toyama, Japan), for critical review of the manuscript.

1.
Saarnivaara L, Klemola UM, Lindgren L, Rautiainen P, Suvanto A: QT interval of the ECG, heart rate and arterial pressure using propofol, methohexital or midazolam for induction of anaesthesia. Acta Anaesthesiol Scand 1990; 34: 276–81
2.
McConachie I, Keaveny JP, Healy TE, Vohra S, Million L: Effect of anaesthesia on the QT interval. Br J Anaesth 1989; 63: 558–60
3.
Bazett HC: An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353–70
4.
Yanowitz F, Preston JB, Abildskov JA: Functional distribution of right and left stellate innervation to the ventricles: Production of neurogenic electrocardiographic changes by unilateral alteration of sympathic tone. Circ Res 1966; 18: 416–28
5.
Medak R, Benumof JL: Perioperative management of the prolonged Q-T interval syndrome. Br J Anaesth 1983; 55: 361–4
6.
Galloway PA, Glass PSA: Anesthetic implications of prolonged QT interval syndromes. Anesth Analg 1985; 64: 612–20
7.
Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C: Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000; 17: 662–4
8.
Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F: Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol. Anaesthesia 2001; 56: 248–71
9.
Sellgren J, Ejnell H, Elam M, Ponten J, Wallin BG: Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. A nesthesiology 1994; 80: 534–44
10.
Zhou W, Fontenot HJ, Liu S, Kennedy RH: Modulation of cardiac calcium channels by propofol. A nesthesiology 1997; 86: 670–5
11.
Buljubasic N, Marijic J, Berczi V, Supan DF, Kampine JP, Bosnjak ZJ: Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. A nesthesiology 1996; 85: 1092–9
12.
Saint DA: The effects of propofol on macroscopic and single channel sodium currents in rat ventricular myocytes. Br J Pharmacol 1998; 124: 655–62
13.
Schwartz PJ, Wolf S: QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 55: 1074–7
14.
Forssel G, Orinius E: QT prolongation and ventricular fibrillation in acute myocardial infarction. Acta Med Scand 1981; 210: 309–11
15.
Wolfe CL, Nibley C, Bhandari A, Chatterjee K, Scheinman M: Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 1991; 84: 1543–51